Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > Good luck this week my fellow long shareholders

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Nov 01, 2021 12:16pm

66 Views

Post# 34073454

RE:RE:RE:RE:Good luck this week my fellow long shareholders

So you didn't comment on anything in GrahamB's first post and chose to defer to AD in his second post.......way to defend your position Rosenberg.....why don't you take a crack at the first one again......we'd love to hear your response....

DavidRosenberg wrote:

GrahamB wrote: Thanks for the kind words Mil man.

To the point |David, here are the key questions that may be of interest to those consiodering a purchase of FSD:

So Lucid is partly owned by Durkacz and so its a related party transaction, meaning he benefited from FSD purchasing LUCID ?

What was the value of Lucid BEFORE FSD bought them for 11 million ?(ie-perhaps the value during the most recent financing)

How much did the LUCID owners benefit from the buyout by the premium paid by FSD?

Was there a transaction cost billed to FSD by First republic?

What is the molecule?

(Is this a psilocybin generic-so back to the cannabis story again-commodity and ADs "race to the bopttom"?

What/where is the evidence of preclinical or clinical efficaCY OF THE MYSTERY MOLECULES being promoted fopr depresssion and MS?

why don't you contact Anthony for the lucid transaction details ?

as for the molecule I am also interested to see where does it stand , I would also like to see some evidence of efficacy but it's a NCE right ? The value lies with UHN doing 10 years of research on the molecule how would that translate into benefiting shareholders remains to be seen we need to see hard proof that it works I agree with you and milman on that point ...

adurkacz@fsdpharma.com Here is his email feel free to ask him instead of me about the business transaction between lucid and fsd etc